HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Abstract
Breast cancer is the most common form of cancer diagnosed in women worldwide and the second leading cause of cancer-related deaths in the USA. Despite the development of newer diagnostic methods, selective as well as targeted chemotherapies and their combinations, surgery, hormonal therapy, radiotherapy, breast cancer recurrence, metastasis and drug resistance are still the major problems for breast cancer. Emerging evidence suggest the existence of cancer stem cells (CSCs), a population of cells with the capacity to self-renew, differentiate and be capable of initiating and sustaining tumor growth. In addition, CSCs are believed to be responsible for cancer recurrence, anticancer drug resistance, and metastasis. Hence, compounds targeting breast CSCs may be better therapeutic agents for treating breast cancer and control recurrence and metastasis. Naturally occurring compounds, mainly phytochemicals have gained immense attention in recent times because of their wide safety profile, ability to target heterogeneous populations of cancer cells as well as CSCs, and their key signaling pathways. Therefore, in the present review article, we summarize our current understanding of breast CSCs and their signaling pathways, and the phytochemicals that affect these cells including curcumin, resveratrol, tea polyphenols (epigallocatechin-3-gallate, epigallocatechin), sulforaphane, genistein, indole-3-carbinol, 3, 3'-di-indolylmethane, vitamin E, retinoic acid, quercetin, parthenolide, triptolide, 6-shogaol, pterostilbene, isoliquiritigenin, celastrol, and koenimbin. These phytochemicals may serve as novel therapeutic agents for breast cancer treatment and future leads for drug development.
AuthorsPrasad R Dandawate, Dharmalingam Subramaniam, Roy A Jensen, Shrikant Anant
JournalSeminars in cancer biology (Semin Cancer Biol) Vol. 40-41 Pg. 192-208 (10 2016) ISSN: 1096-3650 [Electronic] England
PMID27609747 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2016. Published by Elsevier Ltd.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Phytochemicals
  • Plant Extracts
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology, therapeutic use)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Proliferation
  • Cell Survival
  • Humans
  • Neoplastic Stem Cells (drug effects, physiology)
  • Phytochemicals (pharmacology, therapeutic use)
  • Plant Extracts (pharmacology, therapeutic use)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: